Kenvue launches Tylenol Kenvue Maker transformation plans. How should you play Kvue shares here?

Kenvue (KVue) shares were focused on Monday after its CEO, Thibau Mongon, and announced a strategic review aimed at improving the wallet.

In a press release in a press statement on July 14.

At the time of writing this report, Kenvue’s shares decreased by more than 13 % against a year to date in May.

The leadership of Kenvue and the strategic review can be proven positively positive for its stock price because it indicates a pre -emptive reset aimed at opening the value of the shareholders.

The company headquartered at the summit appointed New Jersey Kirk Perry, an experienced executive official with deep experience in consumer goods and data -based shift, indicating a complete commitment to operational discipline.

In addition, a review of the Board of Directors can strip the brand, cost savings, and simplify the wallet, all of which may improve margins and focus over time.

Simply put, the change of management and strategic review today about KVUE’s jobs to implement the strongest and long -term growth.

Kenvue shares are currently being traded just a little higher than the price they started this year, a weakness called Jefferies analysts an opportunity to buy a quality name with a deep discount in the last research note.

In June, the investment company was described as a “self -assistance transformation story” because it repeated its “purchase” classification on the consumer health company.

According to Jefferies, improving retail trends and early recovery in major brands such as Neutrogena and Zyrtec can see KVUE shares up to $ 27 (an increase of more than 27 % of here) over the next 12 months.

The revenue of profit distributions is compensated for 3.74 % for another large reason for Kenvue in the second half of 2025.

Although it is not as bullish like Jefferies, other Wall Street companies also recommend buying Kvue shares at the current levels.

According to Barchart, the category of consensus is sitting on Kenvue’s shares currently at “Buy Modra Buy” with the average goal of $ 24.50, indicating a possible increase in more than 12 % of here.

On the date of publication, Wajeeh Khan did not have positions (either directly or indirectly) in any of the securities mentioned in this article. All information and data in this article are only for media purposes. This article was originally published on Barchart.com